The most significant data comes from a tirzepatide study that paired the medication with low-energy ketogenic therapy
Research from Levity, a digital health platform providing behavioral support and emotional tracking tools for people using GLP-1 medications, now shows that nearly one in three GLP-1 users admit to skipping or delaying a dose to avoid the logistics or embarrassment of traveling with injectables like Ozempic, Wegovy, or Mounjaro
From cardiovascular and neurodegenerative diseases to chronic kidney disease, osteoarthritis, liver health, sleep apnea, addiction, and fertility issues, these medications offer new hope for managing complex health conditions and improving patient lives
G protein dissociation studies (TRUPATH) G protein dissociation was measured using the TRUPATH biosensor platform [21]
Effects of prebiotics on postprandial GLP-1, GLP-2 and glucose regulation in patients with type 2 diabetes: A randomised, double-blind, placebo-controlled crossover trial
Slowly, the body starts to adjust its metabolism and tolerate the medication with minimal side effects
